#435 – Carolyn Starrett, CEO at Flatiron Health

Share This Post

Cancer Care & Research - Episode Details

Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Carolyn Starrett, CEO at Flatiron Health.

What you’ll get out of this episode:
  • Carolyn Starrett’s Journey and Flatiron Health’s Mission: Carolyn Starrett, CEO of Flatiron Health, shares her experience and the company’s mission to utilize machine learning and real world data to transform cancer treatment and research.
  • The Independent Subsidiary Structure Post-Acquisition: Starrett discusses the benefits of operating as an independent subsidiary within the Roche Group, allowing Flatiron Health to maintain its unique culture and focus while benefiting from the long-term strategic vision of a larger organization.
  • International Expansion and Learning from Global Patient Populations: She explains the strategic expansion into the UK, Germany, and Japan, aiming to learn from diverse patient experiences and work with regulators to improve access to novel medicines globally.
  • Building an International Team and Overcoming Cultural Challenges: Starrett shares insights on the complexities and rewards of building a team across different countries, emphasizing the need for local expertise and a deep understanding of varying healthcare systems.
  • Advancements in Real World Evidence (RWE) and Partnerships: Carolyn discusses how Flatiron Health is not only parsing and harmonizing real world data but also generating insights and solutions with partners like Sanofi, improving the efficiency and impact of clinical trials.

Watch

Listen

Read About Cancer Care

Flatiron Health’s Approach to Cancer Research

Under Carolyn Starrett’s leadership, Flatiron Health is making significant strides in cancer research using machine learning and real world data. Their work involves not just curating vast amounts of data but also generating valuable insights that inform new therapies and decision-making in drug development. Starrett’s unique perspective, shaped by her years at Flatiron and its journey from a private entity to an independent subsidiary of Roche, offers a nuanced understanding of the healthcare and pharmaceutical landscape.

International Expansion and Its Impact

Starrett highlights Flatiron Health’s international expansion, focusing on patient populations in the UK, Germany, and Japan. This global approach allows the company to glean insights from diverse patient experiences and contribute to the broader field of cancer research. The partnership with the NHS Trust in Leeds is a notable step in bringing together a range of experts to turn patient experiences into actionable data and evidence.

Challenges and Opportunities in Building a Global Team

Building an international team presents unique challenges, from navigating different healthcare systems to integrating various cultures and work ethics. Starrett emphasizes the importance of local understanding and expertise in each market to tailor their approach effectively. This strategy enables Flatiron Health to resonate with and meet the needs of diverse patient populations and healthcare systems.

Expanding into Real World Evidence Services

Flatiron Health is moving beyond data curation to actively shaping how real world evidence is used in drug development. Starrett is excited about collaborations like the one with Sanofi, aiming to streamline clinical trials and make the drug development process more efficient. This approach is expected to accelerate the availability of new treatments and improve patient outcomes.

Future Prospects and Advice for New Leaders in Healthcare

Looking ahead, Starrett is enthusiastic about the potential breakthroughs in clinical trial processes and patient care improvements. Her advice to new entrepreneurs and leaders in healthcare is to stay focused, collaborate effectively, and be prepared for the long haul, as transformation in this sector requires persistence and a clear vision.

 


WORD FROM OUR SPONSORS:

Our sponsors for this episode are Sage Growth Partners and Quantum Health

 

Sage Growth Partners Thumbnail for digital health use on Slice of Healthcare's website.

Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners

Quantum Health's Thumbnail for digital health use on Slice of Healthcare's website

Quantum Health is an award-winning consumer healthcare navigation company that delivers an unparalleled consumer experience based on empathy and trust, enabling employers to achieve industry-leading satisfaction rates and independently validated claim savings. Launched in 1999, Quantum Health’s model is based on years of consumer research and the insights learned from guiding millions of consumers and their providers through their healthcare journey. Visit: https://quantum-health.com/ and follow Quantum health on social media – @Quantum Health

Finally, to learn more about our guest and their company please use the links below:

Guest’s LinkedInCompany LinkedInWebsite


Also, be sure to follow Slice of Healthcare on our social channels:

Website  – LinkedIn – Twitter – YouTube – Newsletter

More To Explore

Total
0
Share